Bengaluru (Karnataka) [India], Sept 20 (ANI): Strides Pharma Science said on Friday that its board of directors has approved an additional investment of up to 40 million dollars (about Rs 290 crore) over the next two years for a controlling stake in its associate company Stelis Biopharma.
Bengaluru (Karnataka) [India], Sep 13 (ANI): Biopharmaceutical major Biocon has signed a license and supply agreement with a subsidiary of China Medical System (CMS) Holdings Ltd for three generic formulation products in Greater China.
Mumbai (Maharashtra) [India], Sep 11 (ANI): The board of directors at biopharmaceutical major Sanofi India has approved a transaction for the slump sale and transfer of its manufacturing facility at Ankleshwar in Gujarat to Zentiva for a consideration of Rs 261.7 crore.
Bengaluru (Karnataka) [India], Aug 27 (ANI): Strides Pharma Science Ltd said on Tuesday that its step-down subsidiary Strides Pharma Inc has acquired a manufacturing facility in Florida from Micelle BioPharma Inc.
Bengaluru (Karnataka) [India], Aug 22 (ANI): Biopharmaceutical major Biocon said on Thursday said its insulin facility in Malaysia has been approved by the European Medicines Agency.
Bengaluru (Karnataka) [India], July 26 (ANI): Biopharmaceutical major Biocon has reported 72 per cent jump in its consolidated net profit at Rs 206 crore during the quarter ended June 30 as opposed to Rs 120 crore during the corresponding quarter last fiscal.
New Delhi [India], July 1 (ANI-BusinessWireIndia): In a bid to create a globally competitive biopharmaceutical industry that addresses the country's major concerns around barriers to affordable healthcare, Hon'ble Minister Dr. Harsh Vardhan, Union Minister of Science & Technolo
New Delhi [India] May 17 (ANI): The Cabinet Committee on Economic Affairs chaired by Prime Minister Narendra Modi on Wednesday gave its approval for Industry-Academia Collaborative Mission for accelerating discovery research to early development for biopharmaceuticals, "Innovate in Indi
New Delhi, Aug 8 (ANI): Tata Trusts has announced signing of an agreement with the US-headquartered biopharmaceutical company Gilead Sciences to explore collaboration to tackle the viral hepatitis in the country, a release stated.